There was a question that got raised at the last meeting about work product, and if pharmaceutical companies get access to the prescriptions that doctors are writing through pharmacists and then go back and it becomes a marketing tool for them, it seems to me that could also raise insurance premiums. I'm wondering if your sector has a concern about the potential for that work product in terms of marketing use.
On March 26th, 2015. See this statement in context.